1 |
physiologically based pharmacokinetic
(2644 times)
|
Pharmacology (1209 times)
|
PK (256 times) AUC (149 times) ddI (130 times)
|
1987 Adjusting exposure limits for long and short exposure periods using a physiological pharmacokinetic model.
|
2 |
physiologically based PK
(40 times)
|
Pharmacology (27 times)
|
PK (32 times) ADME (6 times) PD (6 times)
|
2011 The impact of hepatic uptake on the pharmacokinetics of organic anions.
|
3 |
physiologically-based models of dioxin pharmacokinetics
(2 times)
|
Pharmacology (1 time)
|
CGE (1 time) i.v (1 time) PS-ODN (1 time)
|
1995 Biologically-based models of dioxin pharmacokinetics.
|
4 |
paediatrics and adults.Physiologically based pharmacokinetics
(1 time)
|
Toxicology (1 time)
|
AUC (1 time) DDI (1 time) i.v (1 time)
|
2021 Drug-drug interaction comparison between tacrolimus and phenobarbital in different formulations for paediatrics and adults.
|
5 |
physiologically based pharmacokinetic software routine
(1 time)
|
Pharmacology (1 time)
|
---
|
2002 PKQuest: capillary permeability limitation and plasma protein binding - application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics.
|
6 |
Physiologically based pharmacokinetic/toxicokinetic
(1 time)
|
Toxicology (1 time)
|
---
|
2005 Vinyl chloride-a classical industrial toxicant of new interest.
|
7 |
physiologically based PK models
(1 time)
|
Pharmacology (1 time)
|
PK (1 time)
|
2019 Assessment and Confirmation of Species Difference in Nonlinear Pharmacokinetics of Atipamezole with Physiologically Based Pharmacokinetic Modeling.
|
8 |
population-based pharmacokinetic
(1 time)
|
Drug Therapy (1 time)
|
BCS (1 time) GI (1 time) PBCS (1 time)
|
2012 Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.
|